Urinary tract infections and lupus erythematosus
Open Access
- 1 April 2004
- journal article
- other
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 63 (4), 431-437
- https://doi.org/10.1136/ard.2003.006346
Abstract
Background: Infections are one of the main causes of morbidity and mortality in patients with systemic lupus erythematosus. Objective: To analyse urinary tract infection (UTI) risk factors in lupus patients; the influence of these factors on disease activity, organ damage, and disease development; the type and prevalence of UTI; and the micro-organisms involved. Method: 86 control subjects and 81 lupus patients were studied prospectively over a 12 month period and examined on five occasions. Epidemiological data and information on urinary symptoms, disease activity (SLEDAI), and organ damage (SLICC/ACR) data were collected. Autoantibodies, complement levels, urine culture, and antibiogram were determined; urological studies were also carried out. SPPS 10.0 and STATA 6.0. were used for statistical analysis. Results: The prevalence of UTI in lupus patients was 36%. Lupus influences the onset of UTI (p = 0.001), regardless of other variables. UTI risk factors in lupus patients were age (p = 0.002), previous cases of UTI (p = 0.0001), antinuclear antibodies (ANA) >1/80 IU/ml (p = 0.022), thrombocytopenia (p = 0.02), and admission to hospital due to UTI (p = 0.002). Leucopenia (p = 0.09) and the weekly administration of methotrexate (p = 0.06) had a bearing on the onset of UTI; disease development (p = 0.99), lupus activity (p = 0.32), and organ damage (p = 0.36) do not. The uropathogen most frequently isolated was E coli (60%). Conclusions: Lupus patients are likely to have UTI, usually manifesting in the lower tract. They are community acquired, basically caused by E coli, and favoured by age, previous UTI, admissions to hospital due to UTI, thrombopenia, ANA, leucopenia, and methotrexate treatments.This publication has 53 references indexed in Scilit:
- Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2001
- New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular targetJournal of Antimicrobial Chemotherapy, 2000
- Urinary incontinence and urinary tract infections in octogenarian womenActa Obstetricia et Gynecologica Scandinavica, 1998
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Risk factors for infection in Malaysian patients with systemic lupus erythematosusQJM: An International Journal of Medicine, 1996
- Hydration monitoring in the prevention of recurrent idiopathic urinary tract infections in pre‐menopausal womenBJU International, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjogren's syndrome.Annals Of The Rheumatic Diseases, 1992
- Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activationClinical Immunology and Immunopathology, 1991
- Systemic lupus erythematosus. Treatment-related complications superimposed on chronic diseaseJAMA, 1990